Canandaigua National Bank & Trust Co. acquired a new position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 1,231 shares of the semiconductor company’s stock, valued at approximately $607,000.
A number of other hedge funds have also recently modified their holdings of the business. Assenagon Asset Management S.A. increased its stake in shares of Synopsys by 1,583.5% in the 3rd quarter. Assenagon Asset Management S.A. now owns 241,906 shares of the semiconductor company’s stock worth $119,354,000 after acquiring an additional 227,537 shares in the last quarter. Cullen Investment Group LTD. grew its holdings in Synopsys by 9.9% in the third quarter. Cullen Investment Group LTD. now owns 3,553 shares of the semiconductor company’s stock worth $1,667,000 after purchasing an additional 320 shares during the period. Union Bancaire Privee UBP SA increased its stake in shares of Synopsys by 235.6% during the third quarter. Union Bancaire Privee UBP SA now owns 18,613 shares of the semiconductor company’s stock valued at $9,183,000 after purchasing an additional 13,066 shares in the last quarter. Sanders Morris Harris LLC bought a new stake in shares of Synopsys in the 3rd quarter worth approximately $216,000. Finally, Gradient Investments LLC boosted its position in shares of Synopsys by 3.1% in the 3rd quarter. Gradient Investments LLC now owns 42,524 shares of the semiconductor company’s stock worth $20,981,000 after purchasing an additional 1,287 shares in the last quarter. Institutional investors own 85.47% of the company’s stock.
Synopsys Price Performance
NASDAQ SNPS opened at $453.07 on Thursday. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73. The stock has a 50-day moving average of $434.22 and a 200 day moving average of $504.07. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. The company has a market capitalization of $84.16 billion, a price-to-earnings ratio of 56.70, a PEG ratio of 3.85 and a beta of 1.16.
Insider Buying and Selling
In other Synopsys news, CAO Sudhindra Kankanwadi sold 9,873 shares of the business’s stock in a transaction on Monday, September 22nd. The shares were sold at an average price of $500.90, for a total transaction of $4,945,385.70. Following the completion of the sale, the chief accounting officer directly owned 20,520 shares in the company, valued at approximately $10,278,468. The trade was a 32.48% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.62% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research analysts recently weighed in on SNPS shares. Needham & Company LLC raised their price objective on Synopsys from $550.00 to $580.00 and gave the company a “buy” rating in a research report on Thursday, December 11th. Mizuho reduced their price target on Synopsys from $700.00 to $600.00 and set an “outperform” rating for the company in a report on Thursday, September 11th. Stifel Nicolaus lowered their price target on Synopsys from $650.00 to $550.00 and set a “buy” rating for the company in a research report on Wednesday, September 10th. Citigroup initiated coverage on shares of Synopsys in a research report on Monday, November 24th. They set a “buy” rating and a $580.00 price objective on the stock. Finally, Rosenblatt Securities upgraded shares of Synopsys from a “neutral” rating to a “buy” rating and reduced their price objective for the company from $605.00 to $560.00 in a research note on Tuesday, December 9th. Eleven equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Synopsys presently has an average rating of “Moderate Buy” and an average price target of $562.13.
View Our Latest Analysis on Synopsys
Synopsys Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles
- Five stocks we like better than Synopsys
- What is the MACD Indicator and How to Use it in Your Trading
- Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock
- What is a Special Dividend?
- Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
